Citation Impact
Citing Papers
Factors Influencing the Composition of the Intestinal Microbiota in Early Infancy
2006 Standout
Global epidemiology ofTrichomonas vaginalis
2013
Novel therapeutic strategies targeting HIV integrase
2012
Click chemistry-facilitated comprehensive identification of proteins adducted by antimicrobial 5-nitroimidazoles for discovery of alternative drug targets against giardiasis
2020 StandoutNobel
Prevention of perinatal group B streptococcal infection: current controversies
2000
The Relationship Between Infections and Adverse Pregnancy Outcomes: An Overview
2001
Use of antibiotics to prevent preterm birth
1997
Psychological Stress and Disease
2007 Standout
Viral and Bacterial Pathogens at the Maternal‐Fetal Interface
2004
Steady‐state pharmacokinetics of once‐daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers*
2007
Effects of Acid‐Reducing Agents on the Pharmacokinetics of Lopinavir/Ritonavir and Ritonavir‐Boosted Atazanavir
2008
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda
1998
Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy
2015 StandoutNobel
Progression to AIDS
1999
Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?
2014 Standout
Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: a cluster-randomised controlled trial
2008 Standout
Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis
2011
Management of Hepatic Complications in HIV‐Infected Persons
2008
β-Arrestin-biased Agonism at the β2-Adrenergic Receptor
2007 StandoutNobel
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Marine natural products
1990 Standout
WOMEN AND HIV
1997
The Pharmacokinetics of Amprenavir, Zidovudine, and Lamivudine in the Genital Tracts of Men Infected with Human Immunodeficiency Virus Type 1 (AIDS Clinical Trials Group Study 850)
2002
CRISPR–Cas9 genome engineering of primary CD4+ T cells for the interrogation of HIV–host factor interactions
2018 StandoutNobel
Nuclear receptor PXR, transcriptional circuits and metabolic relevance
2011
New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism
2005
Bacterial Communities in Women with Bacterial Vaginosis: High Resolution Phylogenetic Analyses Reveal Relationships of Microbiota to Clinical Criteria
2012
Respiratory Symptoms and Airway Obstruction in HIV-Infected Subjects in the HAART Era
2009
Group B streptococcus
1999
UPLC-MS-MS Method for Simultaneous Determination of Caffeine, Tolbutamide, Metoprolol, and Dapsone in Rat Plasma and its Application to Cytochrome P450 Activity Study in Rats
2012
Clinical Pharmacokinetic and Pharmacodynamic Profile of the HIV Integrase Inhibitor Elvitegravir
2011
Gut microbiome and health: mechanistic insights
2022 Standout
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors
2002
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
The role of sexually transmitted diseases in HIV transmission
2004 Standout
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Penetration enhancers
2003 Standout
Rifamycin‐ResistantMycobacterium tuberculosisin the Highly Active Antiretroviral Therapy Era: A Report of 3 Relapses with Acquired Rifampin Resistance following Alternate‐Day Rifabutin and Boosted Protease Inhibitor Therapy
2009
The Epidemiology and Impact of Traumatic Brain Injury
2006 Standout
A review on recent developments of indole-containing antiviral agents
2014
Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adults
2007
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Midwifery and quality care: findings from a new evidence-informed framework for maternal and newborn care
2014 Standout
New first and second generation inhibitors of human immunodeficiency virus-1 integrase
2011
Intrauterine Infection and Preterm Delivery
2000 Standout
How were new medicines discovered?
2011 Standout
HIV/AIDS: Interactions between Natural Health Products and Antiretroviral Drugs: Pharmacokinetic and Pharmacodynamic Effects
2006
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
2009 Standout
Hepatitis C virus NS5A inhibitors and drug resistance mutations
2014
Stress-induced immune dysfunction: implications for health
2005 Standout
Innate immunity of the newborn: basic mechanisms and clinical correlates
2007 Standout
Periodontal diseases
2005 Standout
Antibacterial macrolides: a drug class with a complex pharmacological profile
2004
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view
2017 Standout
Proline-catalysed Mannich reactions of acetaldehyde
2008 StandoutNatureNobel
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Inhibition of Telomerase Activity by Human Immunodeficiency Virus (HIV) Nucleos(t)ide Reverse Transcriptase Inhibitors: A Potential Factor Contributing to HIV-Associated Accelerated Aging
2013
Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study
2009
The health and health system of South Africa: historical roots of current public health challenges
2009 Standout
The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery
1996
Current race in the development of DAAs (direct-acting antivirals) against HCV
2014
Impact of high-throughput screening in biomedical research
2011 Standout
Chemokine Antagonists as Therapeutics: Focus on HIV-1
2006
Community-Based Interventions for Improving Perinatal and Neonatal Health Outcomes in Developing Countries: A Review of the Evidence
2005
Chemical Constituents and Pharmacological Activities of Garlic (Allium sativum L.): A Review
2020 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms
1998
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Rifampin Combination Therapy for Nonmycobacterial Infections
2010
Risk Factors for Early-onset Group B Streptococcal Sepsis: Estimation of Odds Ratios by Critical Literature Review
1999
Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity
2005
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Discovery and Development of Hepatitis C Virus NS5A Replication Complex Inhibitors
2014
Hepatitis C in the HIV-Infected Person
2003
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Discovery of Novel Small Molecule Orally Bioavailable C−X−C Chemokine Receptor 4 Antagonists That Are Potent Inhibitors of T-Tropic (X4) HIV-1 Replication
2010
Study of Once-Daily Versus Twice-Daily Fosamprenavir plus Ritonavir Administered with Abacavir/Lamivudine Once Daily in Antiretroviral-Naïve HIV-1–Infected Adult Subjects
2009
Interventions for treating genital chlamydia trachomatis infection in pregnancy
1998
Group B Streptococcal Infections
2017
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action
2003
Spermidine in health and disease
2018 StandoutScience
How we detect microbes and respond to them: the Toll-like receptors and their transducers
2003 StandoutNobel
Clinical Implications of CNS Penetration of Antiretroviral Drugs
2002
Correlates of Cervical Mycoplasma genitalium and Risk of Preterm Birth Among Peruvian Women
2010
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
β-Arrestin-biased ligands at seven-transmembrane receptors
2007 StandoutNobel
Central Nervous System Disposition and Metabolism of Fosdevirine (GSK2248761), a Non-Nucleoside Reverse Transcriptase Inhibitor: An LC-MS and Matrix-Assisted Laser Desorption/Ionization Imaging MS Investigation into Central Nervous System Toxicity
2012
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Exogenous spermine inhibits hypoxia/ischemia-induced myocardial apoptosis via regulation of mitochondrial permeability transition pore and associated pathways
2016
2,5-Diketopiperazines: Synthesis, Reactions, Medicinal Chemistry, and Bioactive Natural Products
2012
Assessing Atropisomer Axial Chirality in Drug Discovery and Development
2011 Standout
Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes
2015 Standout
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Preterm labor: One syndrome, many causes
2014 StandoutScience
Prosthetic Joint Infection
2014 Standout
Novel Engagement of CD14 and Multiple Toll-Like Receptors by Group B Streptococci
2001
Pharmacokinetics of [ 14 C]Abacavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Inhibitor, Administered in a Single Oral Dose to HIV-1-Infected Adults: a Mass Balance Study
1999
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
2002 Standout
Works of Yu Lou being referenced
Akt and Erk1/2 activate the ornithine decarboxylase/polyamine system in cardioprotective ischemic preconditioning in rats: the role of mitochondrial permeability transition pores
2014
Metabolic Disposition and Pharmacokinetics of [14C]‐Amprenavir, a Human Immunodeficiency Virus Type 1 (HIV‐1) Protease Inhibitor, Administered As a Single Oral Dose to Healthy Male Subjects
2001
Abacavir: Absolute Bioavailability, Bioequivalence of Three Oral Formulations, and Effect of Food
1999
Overall and cause-specific mortality in a cohort of homo-/bisexual men, injecting drug users, and female partners of HIV-infected men
1996
Coadministration of Esomeprazole With Fosamprenavir Has No Impact on Steady-State Plasma Amprenavir Pharmacokinetics
2006
Evaluation of the Drug Interaction Potential of Aplaviroc, a Novel Human Immunodeficiency Virus Entry Inhibitor, Using a Modified Cooperstown 5 + 1 Cocktail
2006
Colonization with group B streptococci in pregnancy and adverse outcome
1996
Drug interaction profile for GSK2248761, a next generation non‐nucleoside reverse transcriptase inhibitor
2012
Pulmonary function tests in HIV-infected patients without AIDS. Pulmonary Complications of HIV Infection Study Group.
1995
Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults
2005
The Effect of Lopinavir/Ritonavir and Darunavir/Ritonavir on the HIV Integrase Inhibitor S/GSK1349572 in Healthy Participants
2010
Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers
2001
Double‐Blind Placebo‐Controlled Treatment Trial of Chlamydia trachomatis Endocervical Infections in Pregnant Women
1997
Pharmacokinetic Interaction between Amprenavir and Rifabutin or Rifampin in Healthy Males
2001
Pharmacokinetic and Pharmacodynamic Study of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir after Multiple Oral Dosing
2001
Pharmacokinetic Study of Human Immunodeficiency Virus Protease Inhibitors Used in Combination with Amprenavir
2001
Echocardiogram Study To Evaluate the Effect of the Novel Hepatitis C Virus NS5A Inhibitor GSK2336805 on Cardiac Contractility in Healthy Subjects
2013
Safety and Efficacy of GSK2248761, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor, in Treatment-Naive HIV-1-Infected Subjects
2012
Pharmacokinetics and Short-Term Safety of 873140, a Novel CCR5 Antagonist, in Healthy Adult Subjects
2005
Single-Dose Pharmacokinetics of Amprenavir, a Human Immunodeficiency Virus Type 1 Protease Inhibitor, in Subjects with Normal or Impaired Hepatic Function
2000
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GSK2336805, an Inhibitor of Hepatitis C Virus (HCV) NS5A, in Healthy Subjects and Subjects Chronically Infected with HCV Genotype 1
2013
Safety and Pharmacokinetics of Abacavir (1592U89) following Oral Administration of Escalating Single Doses in Human Immunodeficiency Virus Type 1-Infected Adults
1999
Pharmacokinetic Interaction between Fosamprenavir-Ritonavir and Rifabutin in Healthy Subjects
2007
Plasma Amprenavir Pharmacokinetics and Tolerability following Administration of 1,400 Milligrams of Fosamprenavir Once Daily in Combination with either 100 or 200 Milligrams of Ritonavir in Healthy Volunteers
2007
Pharmacokinetic Interaction between Amprenavir and Clarithromycin in Healthy Male Volunteers
2000
Fosamprenavir plus Ritonavir Increases Plasma Ketoconazole and Ritonavir Exposure, while Amprenavir Exposure Remains Unchanged
2007
Double-blind placebo-controlled treatment trial ofChlamydia trachomatis endocervical infections in pregnant women
1997
Multiple-Dose Pharmacokinetics and Pharmacodynamics of Abacavir Alone and in Combination with Zidovudine in Human Immunodeficiency Virus-Infected Adults
2000
Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers
2009
In Vivo Effect of α 1 -Acid Glycoprotein on Pharmacokinetics of Amprenavir, a Human Immunodeficiency Virus Protease Inhibitor
2001
Effect of Antacids and Ranitidine on the Single-Dose Pharmacokinetics of Fosamprenavir
2004